PriceTargets.com logo

SOC Telemed - TLMD Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.00 As of 04/6/2022 01:00 AM ET
+0 (0.00%)
Get New SOC Telemed Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TLMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TLMD

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for SOC Telemed in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $3.00.

This chart shows the closing price for TLMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in SOC Telemed. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/7/2022Credit Suisse GroupBoost TargetNeutral$2.00 ➝ $3.00Low
2/4/2022BenchmarkDowngradeBuy ➝ HoldLow
2/3/2022Robert W. BairdDowngradeOutperform ➝ Neutral$4.00 ➝ $3.00High
2/3/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$6.00 ➝ $3.00High
1/13/2022BenchmarkLower Target$7.00 ➝ $2.00High
1/7/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$6.00 ➝ $2.00High
8/13/2021Royal Bank of CanadaLower TargetPositive ➝ Outperform$10.00 ➝ $6.00High
8/13/2021Credit Suisse GroupLower TargetOutperform$11.00 ➝ $8.50High
8/13/2021BenchmarkLower TargetBuy$10.00 ➝ $7.00High
5/27/2021Robert W. BairdInitiated CoverageOutperform$7.50Low
2/16/2021Credit Suisse GroupInitiated CoverageOutperform$11.00Low
1/28/2021Royal Bank of CanadaInitiated CoverageOutperform$10.00High
1/15/2021BenchmarkInitiated CoverageBuy$12.00High
1/15/2021BTIG ResearchDowngradeBuy ➝ NeutralHigh
1/6/2021BTIG ResearchInitiated CoverageBuy$12.00N/A
11/30/2020Robert W. BairdInitiated CoverageOutperform$12.00Low
11/25/2020William BlairInitiated CoverageOutperformLow
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.88 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
SOC Telemed logo
SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private.
Read More

Today's Range

Now: $3.00
Low: $3.00
High: $3.00

50 Day Range

MA: $2.98
Low: $2.90
High: $3.00

52 Week Range

Now: $3.00
Low: $0.55
High: $8.00

Volume

N/A

Average Volume

1,277,212 shs

Market Capitalization

$302.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of SOC Telemed?

The following sell-side analysts have issued research reports on SOC Telemed in the last year:
View the latest analyst ratings for TLMD.

What is the current price target for SOC Telemed?

0 Wall Street analysts have set twelve-month price targets for SOC Telemed in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for SOC Telemed in the next year.
View the latest price targets for TLMD.

What is the current consensus analyst rating for SOC Telemed?

SOC Telemed currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for TLMD.

What other companies compete with SOC Telemed?

Other companies that are similar to SOC Telemed include Terns Pharmaceuticals, Monte Rosa Therapeutics, Cerus, Inozyme Pharma and AxoGen. Learn More about companies similar to SOC Telemed.

How do I contact SOC Telemed's investor relations team?

SOC Telemed's physical mailing address is 1768 Business Center Drive Suite 100, Reston VA, 20190. The company's listed phone number is 866-483-9690 and its investor relations email address is [email protected]. The official website for SOC Telemed is www.soctelemed.com. Learn More about contacing SOC Telemed investor relations.